<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04470505</url>
  </required_header>
  <id_info>
    <org_study_id>260236</org_study_id>
    <nct_id>NCT04470505</nct_id>
  </id_info>
  <brief_title>Optimizing Platelet Isolation (The Cell Study)</brief_title>
  <official_title>Optimizing Platelet Isolation for Measures of Human Platelet Mitochondrial Respiration (The Cell Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arkansas Children's Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arkansas Children's Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research study is about blood cells (platelets) and their power houses (mitochondria).&#xD;
      The investigators want to learn about their behavior in order to ensure that our laboratory&#xD;
      procedures are generating optimal results.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to assess platelet activation following standard laboratory&#xD;
      procedures used in the process of measuring platelet mitochondrial function, and to determine&#xD;
      the optimal amount of digitonin needed to permeabilize platelet cell membrane.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 6, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet activation from isolated platelets</measure>
    <time_frame>day 1</time_frame>
    <description>Whole blood will be collected following an overnight fast, and platelets isolated using standard procedures. Platelet activation markers (e.g., CD62P ) will be measured using flow cytometric analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Platelet activation measured in whole blood</measure>
    <time_frame>day 1</time_frame>
    <description>Whole blood will be collected following an overnight fast. Platelet activation will be measured in whole blood by the expression CD62P</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet reactivity measured in whole blood</measure>
    <time_frame>day 1</time_frame>
    <description>Whole blood will be collected following an overnight fast. Platelet reactivity will be measured in whole blood with adenosine diphosphate (ADP).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        25-35 years old&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 25-35&#xD;
&#xD;
          -  All races&#xD;
&#xD;
          -  All ethnicity&#xD;
&#xD;
          -  18.5 - 30 BMI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  Aspirin intake&#xD;
&#xD;
          -  Recreational drug use&#xD;
&#xD;
          -  Alcohol intake more than 3 times per week&#xD;
&#xD;
          -  Self-reported possibility of current pregnancy&#xD;
&#xD;
          -  Known diagnosis of:&#xD;
&#xD;
          -  Pre-diabetes&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  High cholesterol&#xD;
&#xD;
          -  High triglycerides&#xD;
&#xD;
          -  Hypertension&#xD;
&#xD;
          -  Anemia&#xD;
&#xD;
          -  Autism spectrum disorder&#xD;
&#xD;
          -  Attention deficit hyperactivity disorder (ADHD)&#xD;
&#xD;
          -  Attention deficit disorder (ADD)&#xD;
&#xD;
          -  Severe asthma&#xD;
&#xD;
          -  Refusal to stop taking nutritional supplements&#xD;
&#xD;
          -  Any other pre-existing medical condition that requires daily medication as determined&#xD;
             by the investigators to affect outcome of interest&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arkansas Children's Nutrition Center</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 2, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

